Cargando…
Association between spironolactone use and COVID-19 outcomes in population-scale claims data: a retrospective cohort study
BACKGROUND: Spironolactone has been proposed as a potential modulator of SARS-CoV-2 cellular entry. We aimed to measure the effect of spironolactone use on the risk of adverse outcomes following COVID-19 hospitalization. METHODS: We performed a retrospective cohort study of COVID-19 outcomes for pat...
Autores principales: | Cousins, Henry C., Altman, Russ B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002773/ https://www.ncbi.nlm.nih.gov/pubmed/36909470 http://dx.doi.org/10.1101/2023.02.28.23286515 |
Ejemplares similares
-
Integrative analysis of functional genomic screening and clinical data identifies a protective role for spironolactone in severe COVID-19
por: Cousins, Henry C., et al.
Publicado: (2023) -
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016) -
COVID-19 severity scale for claims data research
por: Krause, Trudy Millard, et al.
Publicado: (2023) -
Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014) -
Association between Use of Spironolactone and Risk of Stroke in Hypertensive Patients: A Cohort Study
por: Cai, Xintian, et al.
Publicado: (2022)